(Q36895737)

16 August 2017

1 reference

title

DNA vaccines against mycobacterial diseases. (English)

1 reference

16 August 2017

1

1 reference

16 August 2017

1 June 2006

1 reference

16 August 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

16 August 2017

1

1 reference

16 August 2017

1

1 reference

16 August 2017

63-73

1 reference

Direct gene transfer into mouse muscle in vivo

16 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA vaccines against tropical parasitic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Maintenance of serological memory by polyclonal activation of human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA vaccines against human immunodeficiency virus type 1 in the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

On the use of DNA vaccines for the prophylaxis of mycobacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

21 January 2018

Plasmid DNA vaccination

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Developing an epitope-driven tuberculosis (TB) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Immunization with DNA vaccines encoding different mycobacterial antigens elicits a Th1 type immune response in lambs and protects against Mycobacterium avium subspecies paratuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Improved tuberculosis DNA vaccines by formulation in cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA vaccines: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

DNA vaccines for therapy of tuberculosis: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Tuberculosis: a problem with persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

21 January 2018

Immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Progress in the development of tuberculosis vaccines for cattle and wildlife.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Tuberculosis vaccine development; from mouse to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Preclinical testing of new vaccines for tuberculosis: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.63

21 January 2018

Identifiers

DOI

10.2217/17460913.1.1.63

1 reference

16 August 2017

1 reference

PubMed ID

17661686